Compounds > caffeine
Page last updated: 2024-10-24

caffeine and Carcinoma, Ductal, Pancreatic

caffeine has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research Excerpts

ExcerptRelevanceReference
" We aimed to investigate the effects of caffeine and its analog CGS 15943 on hepatocellular carcinoma (HCC) and pancreatic cancer adenocarcinoma (PDAC)."3.80Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway. ( Edling, CE; Falasca, M; Ghonaim, R; Maffucci, T; Selvaggi, F, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edling, CE1
Selvaggi, F1
Ghonaim, R1
Maffucci, T1
Falasca, M1

Other Studies

1 other study available for caffeine and Carcinoma, Ductal, Pancreatic

ArticleYear
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.
    Cancer biology & therapy, 2014, Volume: 15, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Caffeine; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal;

2014